| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.NMD.2010.02.001 |
| P698 | PubMed publication ID | 20207543 |
| P50 | author | Heinz Jungbluth | Q30169368 |
| Jean-Pierre Lin | Q47910134 | ||
| Fatemeh Geranmayeh | Q59095003 | ||
| Christian G E L de Goede | Q74071700 | ||
| Emma M Clement | Q79252592 | ||
| P2093 | author name string | Volker Straub | |
| Caroline Sewry | |||
| Francesco Muntoni | |||
| Louise Brueton | |||
| Gabriel Chow | |||
| Stephen Abbs | |||
| Katherine Bushby | |||
| Carlos de Sousa | |||
| Anne-Marie Childs | |||
| Bryan Lynch | |||
| Anirban Majumdar | |||
| Rachael Mein | |||
| Judith Pagan | |||
| Olivia O'Mahony | |||
| Lucy H Feng | |||
| P433 | issue | 4 | |
| P921 | main subject | phenotype | Q104053 |
| muscular dystrophy | Q1137767 | ||
| P304 | page(s) | 241-250 | |
| P577 | publication date | 2010-03-06 | |
| P1433 | published in | Neuromuscular Disorders | Q1981326 |
| P1476 | title | Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations | |
| P478 | volume | 20 |
| Q49963380 | A Homozygous LAMA2 Mutation of c.818G>A Caused Partial Merosin Deficiency in a Japanese patient. |
| Q27322025 | A splice site mutation in laminin-α2 results in a severe muscular dystrophy and growth abnormalities in zebrafish |
| Q54210538 | Amelioration of Muscle and Nerve Pathology in LAMA2 Muscular Dystrophy by AAV9-Mini-Agrin. |
| Q36915922 | Animal models of muscular dystrophy |
| Q90522821 | Antioxidants Reduce Muscular Dystrophy in the dy2J/dy2J Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy |
| Q41854808 | Bioenergetic Impairment in Congenital Muscular Dystrophy Type 1A and Leigh Syndrome Muscle Cells |
| Q27332340 | Bortezomib Does Not Reduce Muscular Dystrophy in the dy2J/dy2J Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy |
| Q98464776 | Brain Dysfunction in LAMA2-Related Congenital Muscular Dystrophy: Lessons From Human Case Reports and Mouse Models |
| Q55090210 | Child Neurology: LAMA2 muscular dystrophy without contractures. |
| Q48357459 | Comparison of brain MRI findings with language and motor function in the dystroglycanopathies |
| Q40381994 | Comparison of sitting and supine forced vital capacity in collagen VI-related dystrophy and laminin α2-related dystrophy. |
| Q36275198 | Comprehensive target capture/next-generation sequencing as a second-tier diagnostic approach for congenital muscular dystrophy in Taiwan |
| Q28255519 | Congenital muscular dystrophies: a brief review |
| Q37725152 | Congenital muscular dystrophy type 1A with residual merosin expression. |
| Q40120224 | Correction of a splicing defect in a mouse model of congenital muscular dystrophy type 1A using a homology-directed-repair-independent mechanism |
| Q91906240 | Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy |
| Q57292499 | Deletion of exon 4 in LAMA2 is the most frequent mutation in Chinese patients with laminin α2-related muscular dystrophy |
| Q30767612 | Diagnostic approach to the congenital muscular dystrophies |
| Q35304917 | Evidence-based guideline summary: evaluation, diagnosis, and management of congenital muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Asso |
| Q89963758 | Fibrogenesis in LAMA2-Related Muscular Dystrophy Is a Central Tenet of Disease Etiology |
| Q46563168 | Genetic and Clinical Advances of Congenital Muscular Dystrophy |
| Q37915435 | Glia unglued: how signals from the extracellular matrix regulate the development of myelinating glia |
| Q39020042 | Homozygous dystroglycan mutation associated with a novel muscle-eye-brain disease-like phenotype with multicystic leucodystrophy |
| Q64248716 | Identification of Candidate Protein Markers in Skeletal Muscle of Laminin-211-Deficient CMD Type 1A-Patients |
| Q37531866 | Immortalized myogenic cells from congenital muscular dystrophy type1A patients recapitulate aberrant caspase activation in pathogenesis: a new tool for MDC1A research |
| Q33787898 | Improving Reproducibility of Phenotypic Assessments in the DyW Mouse Model of Laminin-α2 Related Congenital Muscular Dystrophy |
| Q64043511 | LAMA2 Congenital Muscle Dystrophy: A Novel Pathogenic Mutation in Bulgarian Patient |
| Q90584743 | LAMA2 gene mutation update: Toward a more comprehensive picture of the laminin-α2 variome and its related phenotypes |
| Q89963755 | Laminin and Integrin in LAMA2-Related Congenital Muscular Dystrophy: From Disease to Therapeutics |
| Q37589611 | Laminin α2 Deficiency-Related Muscular Dystrophy Mimicking Emery-Dreifuss and Collagen VI related Diseases |
| Q42031930 | Learning disabilities in neuromuscular disorders: a springboard for adult life |
| Q99240636 | Limb girdle muscular dystrophy due to LAMA2 gene mutations: new mutations expand the clinical spectrum of a still challenging diagnosis |
| Q47164258 | Linker proteins restore basement membrane and correct LAMA2-related muscular dystrophy in mice. |
| Q36629201 | Merosin-negative congenital muscular dystrophy: Report of five cases |
| Q86291937 | Muscular dystrophies |
| Q91594164 | Muscular dystrophies |
| Q24323215 | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities |
| Q54979072 | Natural disease history of the dy2J mouse model of laminin α2 (merosin)-deficient congenital muscular dystrophy. |
| Q54090777 | Novel LAMA2 Gene Mutations Associated with Merosin-Deficient Congenital Muscular Dystrophy |
| Q99554359 | Novel mutation identification and copy number variant detection via exome sequencing in congenital muscular dystrophy |
| Q28256516 | Prevalence of congenital muscular dystrophy in Italy: a population study |
| Q37446660 | Results of a two-year pilot study of clinical outcome measures in collagen VI- and laminin alpha2-related congenital muscular dystrophies |
| Q22001192 | Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies |
| Q40675087 | Target resequencing of neuromuscular disease-related genes using next-generation sequencing for patients with undiagnosed early-onset neuromuscular disorders |
| Q60300741 | The roles of dystroglycan in the nervous system: insights from animal models of muscular dystrophy |
| Q37607062 | The sensitivity of exome sequencing in identifying pathogenic mutations for LGMD in the United States |
| Q35858762 | Transcriptional Profiling Identifies Location-Specific and Breed-Specific Differentially Expressed Genes in Embryonic Myogenesis in Anas Platyrhynchos |
| Q34100017 | Variable disease severity in Saudi Arabian and Sudanese families with c.3924 + 2 T > C mutation of LAMA2. |
Search more.